Reconsideration of drug release from temperature-sensitive liposomes
Related Experiment Video
Updated: Oct 2, 2026

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
Published on: March 3, 2020
Atsuo Ono1, Kentaro Takeuchi, Akemi Sukenari
1Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Sugitani Toyama, Japan. atsuo@ms.toyama-mpu.ac.jp
Abstract:
The liposomal phase transition temperature was monitored in unstirred suspensions using a differential scanning calorimeter. The main and pre-transition temperatures under conditions of stirring were measured by the change in 90 degrees light scattering using a fluorescence spectrophotometer. Both methods show the same main transition temperature either with or without stirring. Temperature sensitive liposomes were made of DPPC (dipalmitoylphosphatidylcholine), DMPC (dimylisitoylphosphatidylcholine) or DSPC (distearoylphosphatidylcholine). The calcein release profile from the liposomes depends on the stirring time of the liposome suspension at the main transition temperature. For 1 h incubation, the leakage profile with and without stirring is similar. It had been hypothesized that temperature sensitive liposomes released drug at the main-transition temperature. However, calcein leakage from liposomes is observed also at the pre-transition temperature. Thus, a liposomal encapsulated drug will likely leak from DPPC liposomes at body temperature (37 degrees C), even if the liposomes were designed to have a higher main transition temperature.
Related Concept Videos
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-Release Drug Delivery Systems: Overview
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Classification
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
